Article
Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer.
Genes, chromosomes & cancer - 1 May 2011
Vaughn Cecily P, Zobell Scott D, Furtado Larissa V, Baker Christine L, Samowitz Wade S
Abstract excerpt
Mutational analysis of KRAS codons 12 and 13 is standard for patients with metastatic colorectal cancer since mutations in these codons predict lack of response to anti-EGFR therapies. However, even among patients whose tumors are wildtype for KRAS codons 12 and 13, only a subset respond to therapy. Since additional activating mutations downstream of EGFR may also play a role in treatment resistance, we sought to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
